NATIONAL DIABETIC SCREENING PROGRAMME
Kowa Optimed has announced that its latest innovation, the Nonmyd WX 3D, has been approved for the English National Screening Programme for Diabetic Retinopathy in the UK. With over five million people expected to have diabetes in the UK by 2025, and with diabetic retinopathy being the main cause of blindness in the 16-65 year-old age group, the National Screening Programme aims to reduce the risk of sight loss by offering annual screening to diabetic patients for prompt identification and effective treatment of sight-threatening retinopathies.
www.kowa.eu/medicals
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
How Many Surgeries Equal Surgical Proficiency?
Internet, labs, simulators, and assisting surgery all contribute.
Improving Clinical Management for nAMD and DME
Global survey data identify barriers and opportunities.
Are Postoperative Topical Antibiotic Drops Still Needed?
Cataract surgeons debate the benefits of intracameral cefuroxime prophylaxis.
Emerging Technology for Detecting Subclinical Keratoconus
Brillouin microscopy shows promise in clinical studies.
Knowing Iris Repair: Modified Trifold Technique
Part eight of our series covers the modified trifold technique for large iris defects.
It’s All About Biomechanics!
Increasing the pool of patients eligible for refractive surgery.
Uncovering More Safe and Quick Options
Different strategies, such as PresbyLASIK, can offer presbyopes good outcomes.
Topography-Guided PRK for Keratoconus
Improving visual acuity in patients with keratoconus.
Defining AMD Treatment Protocol
Treatments trending to fewer injections for better results.